I-Mab expands global presence with new Hong Kong office

I-Mab, a Chinese-based clinical stage biopharmaceutical company with a U.S. base in Rockville, Monday announced the opening of an office in Hong Kong. The Hong Kong office will serve as a regional hub for capital markets and investor relations activities for I-Mab. The company also has an office in Shanghai. I-Mab is the first China-based global biotech company to successfully complete a ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *